Table 3.
Effects of possible factors in the between-study heterogeneity in the prevalence of KRAF mutations (meta-regression model).
| Factors suspected of developing heterogeneity | Coefficient | Standard error | P-value | |
|---|---|---|---|---|
| Year | 2011 2014 2015 2016 2017 2018 |
-0.40 -0.87 -0.18 -0.08 -1.19 -0.60 |
0.25 0.51 0.28 0.21 0.45 0.29 |
0.11 0.09 0.53 0.70 0.008* 0.03* |
| Location | Birjand Kermanshah Shiraz Tabriz Tehran Yazd |
0.76 1.30 0.85 0.56 1.17 1.30 |
0.61 0.51 0.51 0.53 0.47 0.56 |
0.21 0.01* 0.09 0.30 0.01* 0.02* |
| Tumor grade | Poorly Moderately Well |
-1.29 0.52 0.26 |
1.74 0.46 0.64 |
0.46 0.25 0.68 |
| Tumor stage | 1 & 2 3 & 4 |
-0.62 0.68 |
0.43 0.36 |
0.14 0.06 |
| Tumor location | Colon Rectum |
1.67 -1.67 |
0.90 0.90 |
0.07 0.07 |
| Sex (male) | -0.29 | 1.11 | 0.79 | |
| Mean age | -0.07 | 0.03 | 0.01* | |
| Sample size | 0.0001 | 0.0004 | 0.81 | |